ppt01 t1 - bio-tic to mdr - lyndsey starr
TRANSCRIPT
WWW.PNOCONSULTANTS.NL22-11-2017 [email protected]
BIOECONFIN 2017
TOPIC #1 BIO-TIC TO MODEL DEMONSTRATOR REGIONS: THE EUROPEAN AND REGIONAL STRATEGY FOR BIOECONOMY INVESTMENTS
LYNDSEY STARR
PNO CONSULTANTS (UK OFFICE)
CONTENT
1. THE INDUSTRIAL BIOTECHNOLOGY ROADMAP FOR EUROPE
2. THE EUROPEAN BIOECONOMY STRATEGY
3. MODEL DEMONSTRATOR REGIONS
4. REGIONAL BIOECONOMY STRATEGIES
5. STRATEGIES FOR BIOECONOMY INVESTMENTS
BIOECONFIN 2017
THE INDUSTRIAL BIOTECH ROADMAP FOR EUROPE
THE INDUSTRIAL BIOTECH RESEARCH AND INNOVATION CENTRE
VISION: To establish an overview of the barriers to biotech innovation and find solutions to accelerate the uptake of Industrial Biotechnology in Europe
TOTAL BUDGET: EUR 2,8 Million
WHEN: Sept 2012-Sept 2015
OUTPUT: The Industrial Biotech Roadmap for Europe built around 5 IB product groups with potential for Europe by 2030
BIOECONFIN 2017
THE INDUSTRIAL BIOTECH ROADMAP FOR EUROPE
RECOMMENDATIONS FOR ACTION
Improve opportunities for feedstock producers within the bioeconomy;
Investigate the scope for using novel biomass;
Develop a workforce which can maintain Europe’s competitiveness in industrial biotechnology;
Introduce a long-term, stable and transparent policy and incentive framework to promote the bioeconomy;
Improve public perception and awareness of industrial biotechnology and biobased products;
Identify, leverage and build upon EU capabilities for pilot and demonstration facilities;
Promote the use of co-products;
Improve the bioconversion and downstream processing steps;
Improve access to financing for large scale biorefinery projects;
Develop stronger relationships between conventional and non-conventional players in the value chain.
BIOECONFIN 2017
THE EUROPEAN BIOECONOMY STRATEGY
PROMINENT MARKET BARRIERS AND CHALLENGES HINDER THE BIOECONOMY
MARKET BARRIER AND CHALLENGES POSSIBLE SOLUTIONS
Higher cost of production Innovation-friendly market framework conditions
Uncertainty of future regulation Large investments for biobased production facilities
Volatility of feedstock prices Longer ROI timeframes
Unsupportive regulatory environment Strategic regional approaches
Lack of holistic framework Incentives to reduce time to market
BIOECONFIN 2017
Over 45 nations globally, including 19 EU Member States have developed orare developing individual, bioeconomy strategies.
WHY REGIONAL?
• Priority setting
• Strategic planning and governance
• Coordinated research
• Value chain development
• Industrial and agricultural policies
• Funding and investment
BIOECONFIN 2017
A COMMON REGIONAL VISION FOR BIOCONOMY
THE 6 MODEL DEMONSTRATOR REGIONS
• Kosice (Slovakia)
• Walloon (Belgium)
• Scotland (UK)
• Groningen & Drenthe (The Netherlands)
• Andalucía (Spain)
• South and Eastern Ireland
OPPORTUNITIES IN THE MDR’S
• Support to R&I projects
• Promotion of networks and clusters
• Promotion of technology transfer and technology services
• Training, knowledge exchange and capacity building
• Financial instruments and venture capital measures
BIOECONFIN 2017
Source: Bioeconomy development in EU regions, 2017
SCOTLAND'S BIOECONOMY STRATEGY
STRENGTHS• A wide variety of feedstock and several value
chains defined
• Active involvement of companies and researchorganisations (ScotCHEM Platform, IBioIC, ZWS)
• Established infrastructure (“FEEDER 10” Pipeline,Grangemouth industrial hub)
BIOECONFIN 2017
SCOTLAND'S BIOECONOMY STRATEGYA NOVEL CIRCULAR VALUE CHAIN - Links Whiskey distillery by-products, micro-algae and feed industries to aquaculture
SCOTLAND'S BIOECONOMY STRATEGY
STRATEGIES TO IMPROVE INVESTMENT READINESS
• Bioeconomy policy harmonisation – connecting the dots
• Seaweed harvesting regulation – balance commercial exploitation and natural preservation
• Offshore pipeline conversion – repurposing for CO2
transportation
• Investments and local champions for scale-up toward DEMO
IRELAND’S BIOECONOMY STRATEGYSTRENGTHS• 50km Model Biobased Sustainable Chemical Demonstrator Region (IMBR)• Abundant feedstock (natural resources and waste streams)• Strong base in biogas and agricultural processing• Infrastructure (repurposed Lisheen mine for Bioeconomy Hub)• Clusters and incubation centres• Support for bioeconomy initiatives (IBA, Enterprise Ireland)• Several policy documents
BIOECONFIN 2017
STRATEGIES TO IMPROVE INVESTMENT READINESS• Establishing a bioeconomy campus – Lisheen at the heart of the Irish bioeconomy• Developing a Public Procurement Programme – kick-start commercial investment• Valorisation of agri-waste streams – long term availability and stability of
feedstock• Pilots for underutilised organic residues – recovery of higher added value products
STRATEGIES FOR BIOECONOMY INVESTMENTSFINANCIAL INCENTIVES• Dedicated national grant schemes – fine tuned for the bioeconomy development
• The BBI JU
• Support focused on capital investment – tax rebates
• R&D credits and tax deductions
• European Investment Bank (EIB)
• Actively attracting private investment – VC’s and foreign direct investment
• Coherent blending of public and private investments
• Fiscal disincentives for fossil carbon-intensive products
BIOECONFIN 2017
A strategic and focused approach to sourcing and utilisation of funding will be key to the growth of Europe’s bioeconomy
CONTACT DETAILS
Lyndsey StarrSenior Innovation ConsultantPNO Consultants (UK Office)Email: [email protected]: 00 44-788 405 12 73
www.innovationplace.eu